Research Articles
Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer
Article first published online: 16 APR 2009
DOI: 10.1002/gcc.20663
Copyright © 2009 Wiley-Liss, Inc.
Additional Information
How to Cite
Koski, T. A., Lehtonen, H. J., Jee, K. J., Ninomiya, S., Joosse, S. A., Vahteristo, P., Kiuru, M., Karhu, A., Sammalkorpi, H., Vanharanta, S., Lehtonen, R., Edgren, H., Nederlof, P. M., Hietala, M., Aittomäki, K., Herva, R., Knuutila, S., Aaltonen, L. A. and Launonen, V. (2009), Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer. Genes, Chromosomes and Cancer, 48: 544–551. doi: 10.1002/gcc.20663
Publication History
- Issue published online: 6 MAY 2009
- Article first published online: 16 APR 2009
- Manuscript Accepted: 27 FEB 2009
- Manuscript Received: 16 NOV 2007
Funded by
- European Commission. Grant Number: LSHC-CT-2005-518200
- Academy of Finland. Grant Numbers: 213183, 214268, 212901
- Center of Excellence in Translational Genome-Scale Biology
- Sigrid Juselius Foundation
- Cancer Society of Finland
- Abstract
- Article
- References
- Cited By
Abstract
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a tumor predisposition syndrome with cutaneous and uterine leiomyomatosis as well as renal cell cancer (RCC) as its clinical manifestations. HLRCC is caused by heterozygous germline mutations in the fumarate hydratase (fumarase) gene. In this study, we used array comparative genomic hybridization to identify the specific copy number changes characterizing the HLRCC-associated RCCs. The study material comprised formalin-fixed paraffin-embedded renal tumors obtained from Finnish patients with HLRCC. All 11 investigated tumors displayed the papillary type 2 histopathology typical for HLRCC renal tumors. The most frequent copy number changes detected in at least 3/11 (27%) of the tumors were gains in chromosomes 2, 7, and 17, and losses in 13q12.3-q21.1, 14, 18, and X. These findings provide genetic evidence for a distinct copy number profile in HLRCC renal tumors compared with sporadic RCC tumors of the same histopathological subtype, and delineate chromosomal regions that associate with this very aggressive form of RCC. © 2009 Wiley-Liss, Inc.

1098-2264/asset/olbannercenter.jpg?v=1&s=171ee740767c9043cf5fcac8ef2214d9bb83ee9c)
